Reata Pharmaceuticals (RETA) stock Forecast for 2022 – 2026

Reata Pharmaceuticals (RETA) stock Forecast for 2022 – 2026

Last update: March 23, 2023 (06:54)

Sector: Healthcare

The share price of Reata Pharmaceuticals, Inc. (RETA) now

What analysts predict: $112
52-week High/Low: $95 / $18.47

50/200 Day Moving Average: $55.78 / $37.41

This figure corresponds to the Average Price over the previous 50/200 days. For Reata Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Reata Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Reata Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Reata Pharmaceuticals stock? When should I record a loss on Reata Pharmaceuticals stock? What are analysts' forecasts for Reata Pharmaceuticals stock? What is the future of Reata Pharmaceuticals stock? We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on Reata Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Reata Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Reata Pharmaceuticals stock

The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Reata Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Reata Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 25 88.02 86.13 89.78 4.24
Mar 26 88.41 85.05 89.56 5.30
Mar 27 85.19 83.74 87.36 4.32
Mar 28 86.38 83.14 88.88 6.91
Mar 29 86.60 85.51 89.71 4.91
Mar 30 90.80 87.44 92.48 5.76
Mar 31 89.52 87.87 91.23 3.82
Apr 01 90.24 88.17 91.64 3.94
Apr 02 93.26 91.03 96.57 6.10
Apr 03 93.82 90.35 96.22 6.49
Apr 04 92.60 91.63 94.27 2.88
Apr 05 94.09 92.72 95.45 2.94
Apr 06 95.59 92.01 98.84 7.43
Apr 07 97.22 96.24 100.47 4.39
Apr 08 95.37 94.27 96.70 2.58
Apr 09 94.75 92.14 96.12 4.32
Apr 10 94.23 92.67 95.45 3.00
Apr 11 91.87 89.99 93.30 3.68
Apr 12 92.93 91.58 95.86 4.67
Apr 13 95.21 92.59 97.63 5.45
Apr 14 92.87 89.67 95.80 6.84
Apr 15 90.27 87.43 93.12 6.50
Apr 16 88.24 87.31 91.77 5.10
Apr 17 89.17 87.79 90.91 3.56
Apr 18 92.60 91.07 93.76 2.95
Apr 19 94.27 90.69 97.19 7.17
Apr 20 89.93 88.67 91.32 2.99
Apr 21 91.59 89.95 92.83 3.21
Apr 22 91.78 88.89 93.98 5.73
Apr 23 92.60 91.26 95.29 4.41

Reata Pharmaceuticals Daily Price Targets


Reata Pharmaceuticals Stock Forecast 03-25-2023.

Forecast target price for 03-25-2023: $88.02.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.069%.
Pessimistic target level: 86.13
Optimistic target level: 89.78

Reata Pharmaceuticals Stock Forecast 03-26-2023.

Forecast target price for 03-26-2023: $88.41.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.035%.
Pessimistic target level: 85.05
Optimistic target level: 89.56

Reata Pharmaceuticals Stock Forecast 03-27-2023.

Forecast target price for 03-27-2023: $85.19.
Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.144%.
Pessimistic target level: 83.74
Optimistic target level: 87.36

Reata Pharmaceuticals Stock Forecast 03-28-2023.

Forecast target price for 03-28-2023: $86.38.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 6.463%.
Pessimistic target level: 83.14
Optimistic target level: 88.88

Reata Pharmaceuticals Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $86.60.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.681%.
Pessimistic target level: 85.51
Optimistic target level: 89.71

Reata Pharmaceuticals Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $90.80.
Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.449%.
Pessimistic target level: 87.44
Optimistic target level: 92.48

RETA (RETA) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Apr. 81.17 77.43 86.20 10.17
May. 81.65 74.30 91.61 18.89
Jun. 77.57 74.47 84.40 11.76
Jul. 79.74 67.78 88.19 23.15
Aug. 67.14 63.92 70.63 9.51
Sep. 65.26 62.00 75.44 17.82
Oct. 66.57 58.58 72.69 19.41
Nov. 63.64 55.24 73.44 24.78
Dec. 61.60 52.73 69.61 24.25

Reata Pharmaceuticals forecast for this year


Reata Pharmaceuticals Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $81.1651. Pessimistic: $77.43. Optimistic: $86.20


Reata Pharmaceuticals Stock Prediction for May 2023

An uptrend is forecast for this month with an optimal target price of $81.6521. Pessimistic: $74.30. Optimistic: $91.61


Reata Pharmaceuticals Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $77.5695. Pessimistic: $74.47. Optimistic: $84.40


Reata Pharmaceuticals Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $79.7415. Pessimistic: $67.78. Optimistic: $88.19


Reata Pharmaceuticals Stock Prediction for Aug 2023

An downtrend is forecast for this month with an optimal target price of $67.1423. Pessimistic: $63.92. Optimistic: $70.63


Reata Pharmaceuticals Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $65.2623. Pessimistic: $62.00. Optimistic: $75.44


Reata Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $66.5676. Pessimistic: $58.58. Optimistic: $72.69


Reata Pharmaceuticals Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $63.6386. Pessimistic: $55.24. Optimistic: $73.44


Reata Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $61.6022. Pessimistic: $52.73. Optimistic: $69.61



Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 70.60 66.64 74.69 10.77
Feb 76.24 65.87 83.87 21.45
Mar 64.20 55.98 72.54 22.83
Apr 72.16 65.37 78.65 16.88
May 76.49 65.32 83.52 21.79
Jun 74.35 68.70 80.29 14.44
Jul 70.78 61.58 78.99 22.04
Aug 76.44 71.70 86.99 17.57
Sep 74.76 64.89 83.88 22.64
Oct 71.62 63.88 81.21 21.34
Nov 71.62 61.16 76.63 20.19
Dec 73.34 68.35 79.35 13.86

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 73.04 67.93 84.58 19.69
Feb 78.59 70.26 84.57 16.91
Mar 83.62 73.09 89.48 18.32
Apr 99.51 84.39 112.25 24.82
May 93.14 83.08 107.30 22.57
Jun 109.54 102.53 120.27 14.75
Jul 99.90 95.50 115.88 17.59
Aug 84.71 73.36 94.71 22.54
Sep 77.94 73.26 88.69 17.40
Oct 82.77 79.13 89.56 11.65
Nov 81.28 74.78 88.43 15.44
Dec 77.87 68.83 87.21 21.07

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 84.25 80.54 96.38 16.43
Feb 85.43 76.54 89.87 14.83
Mar 98.24 88.22 112.59 21.64
Apr 111.41 97.82 118.76 17.64
May 126.34 108.90 135.18 19.44
Jun 131.64 122.17 144.55 15.48
Jul 121.11 114.81 139.52 17.71
Aug 125.71 113.90 136.28 16.42
Sep 133.01 114.12 147.37 22.56
Oct 126.09 111.46 131.13 15.00
Nov 144.25 132.13 152.04 13.09
Dec 154.63 138.55 174.12 20.43

Reata Pharmaceuticals (RETA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 179.68 155.61 206.99 24.83
Feb 206.99 186.71 239.29 21.97
Mar 187.12 171.03 216.69 21.07
Apr 213.69 204.72 229.51 10.80
May 233.78 211.81 269.78 21.49
Jun 268.85 256.48 309.71 17.19
Jul 266.70 233.63 293.37 20.36
Aug 267.23 239.97 291.82 17.77
Sep 256.01 243.21 279.05 12.84
Oct 213.51 182.34 230.16 20.78
Nov 192.16 174.48 202.15 13.69
Dec 202.54 186.33 215.09 13.37

Reata Pharmaceuticals information and performance

Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.

Reata Pharmaceuticals Address

5320 LEGACY DRIVE, PLANO, TX, US

Market Capitalization: 3 263 096 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -276 904 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -8.53

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -1
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 316.34

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.746

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 32100500

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.